• Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Media Articles

Explore insightful coverage and perspectives on Syngene from various media outlets.
How Syngene International CFO Deepak Jain is Navigating Growth and Innovation in the Biotech Frontier.
26th Jun, 2025
Syngene Charts Global Biologics Growth with India at Its Core
26th Jun, 2025
Syngene’s U.S. Expansion in Bayview Baltimore Establishes Foundation for A Customer-Centric, Globally Connected CRDMO Strategy
23rd Jun, 2025
Formulating OSDs for Poorly Soluble Drugs
13th Jun, 2025
Base to Base biotech podcast 13: Syngene commits to US market, and Nimbus Therapeutics on computational chemistry
12th Jun, 2025
Syngene’s acquisition of its first US manufacturing facility not due to geopolitical tensions
8th Jun, 2025

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details